HANNA JUNG: Open Payments
NPI 1447911284 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 24 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $49 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $113 |
| Lilly USA, LLC | 3 | $68 |
| ABBVIE INC. | 2 | $61 |
| Exact Sciences Corporation | 2 | $49 |
| Bausch Health US, LLC | 2 | $44 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: BREZTRI, Cologuard Collection Kit, MOUNJARO, FARXIGA, APLENZIN, ZENPEP, VERQUVO, JARDIANCE.
Industry payments across CA — which companies pay providers there.
